Aliment Pharmacol Ther

1. NORGARD BM, Thorarinsson CT, Zegers FD, Kjeldsen J, et al
   The use of opioids nine months after surgery for Crohn's disease - a nationwide cohort study.
   Aliment Pharmacol Ther. 2024 May 1. doi: 10.1111/apt.18014.
   

   >> Share

   
   

   
   Am J Gastroenterol

2. WU S, Liu Y, He Z, Bai Y, et al
   The Association Between Ultra-Processed Foods and Inflammatory Bowel Disease: Far More Complex Than Thought.
   Am J Gastroenterol. 2024 May 3. doi: 10.14309/ajg.0000000000002815.
   

   >> Share

   
   
3. ABREU MT, Kosinski LR
   How Did It Get So Difficult to Care for Patients With Inflammatory Bowel Disease?
   Am J Gastroenterol. 2024 Apr 30. doi: 10.14309/ajg.0000000000002794.
   

   >> Share

   
   
4. BERNSTEIN CN, Fisk JD, Dolovich C, Hitchon CA, et al
   Understanding Predictors of Fatigue Over Time in Persons With Inflammatory Bowel Disease: The Importance of Depressive and Anxiety Symptoms.
   Am J Gastroenterol. 2024;119:922-929.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. BARNES A, Toson B, Bryant RV, Mukherjee S, et al
   Latent profiles of fatigue in inflammatory bowel disease.
   BMC Gastroenterol. 2024;24:148.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

6. PAPAMICHAEL K, Centritto A, Guillo L, Hier J, et al
   Higher adalimumab concentration is associated with complete fistula healing in patients with perianal fistulizing Crohn's disease.
   Clin Gastroenterol Hepatol. 2024 Apr 29:S1542-3565(24)00397.
   

   >> Share

   
   

   
   Dig Dis Sci

7. MEDAWAR E, Djinbachian R, Crainic IP, Safih W, et al
   Serrated Polyps in Inflammatory Bowel Disease Indicate a Similar Risk of Metachronous Colorectal Neoplasia as in the General Population.
   Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08456.
   

   >> Share

   
   
8. SCHREIBER S, Hunter Gibble T, Panaccione R, Rubin DT, et al
   Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
   Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08434.
   

   >> Share

   
   
9. GREYWOODE R, Larson J, Peraza J, Clark R, et al
   Risk of Adverse Cardiovascular Outcomes in Postmenopausal Women with Inflammatory Bowel Disease.
   Dig Dis Sci. 2024 Apr 29. doi: 10.1007/s10620-024-08348.
   

   >> Share

   
   

   
   Dis Colon Rectum

10. MASPERO M, Lavryk O, Holubar SD, Lipman JM, et al
    Third Time's the Charm? Indications and Outcomes for Redo-Redo IPAA.
    Dis Colon Rectum. 2024;67:805-811.
    

    >> Share

    
    
11. HUSAIN SG
    Improvised Techniques for Enhanced Detection of Crohn's Strictures During Surgery.
    Dis Colon Rectum. 2024;67:e359.
    

    >> Share

    
    

    
    Eur J Gastroenterol Hepatol

12. CHHIBBA T, Wong ECL, Reinisch W, Targownik L, et al
    Comparing the efficacy of vedolizumab between males and females: a post-hoc analysis of GEMINI-1 and VARSITY.
    Eur J Gastroenterol Hepatol. 2024;36:704-711.
    

    >> Share

    
    

    
    Gastroenterol Hepatol

13. RODRIGUEZ-MORANTA F, Arguelles-Arias F, Hinojosa Del Val J, Iborra Colomino M, et al
    Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis.
    Gastroenterol Hepatol. 2024;47:522-552.
    

    >> Share

    
    

    
    Gastroenterology

14. HONAP S, Sands BE, Jairath V, Danese S, et al
    Basket, Umbrella, and Platform Trials: The Potential for Master Protocol -Based Trials in Inflammatory Bowel Disease.
    Gastroenterology. 2024 Apr 25:S0016-5085(24)00485.
    

    >> Share

    
    

    
    Inflamm Bowel Dis

15. VERNON-ROBERTS A, Chan P, Christensen B, Havrlant R, et al
    Pediatric to Adult Transition in Inflammatory Bowel Disease: Consensus Guidelines for Australia and New Zealand.
    Inflamm Bowel Dis. 2024 May 3:izae087. doi: 10.1093.
    

    >> Share

    
    
16. QIAN XX
    The Association of Extra-oral Halitosis With Small Intestinal Bacterial Overgrowth in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 May 2:izae056. doi: 10.1093.
    

    >> Share

    
    
17. 
    Correction to: Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
    Inflamm Bowel Dis. 2024 Apr 27:izae096. doi: 10.1093.
    

    >> Share

    
    
18. WANG Y, Pan CW, Huang Y, Zheng X, et al
    Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019.
    Inflamm Bowel Dis. 2024 Apr 27:izae093. doi: 10.1093.
    

    >> Share

    
    
19. YANG C, Merlin D
    Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model.
    Inflamm Bowel Dis. 2024;30:844-853.
    

    >> Share

    
    
20. SCHWARTZBERG DM, Kayal M, Barnes EL
    The Ileal Pouch-Anal Anastomosis: Identifying Structural Disorders.
    Inflamm Bowel Dis. 2024;30:863-867.
    

    >> Share

    
    
21. COOK L, Wong MQ, Rees WD, Schick A, et al
    Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
    Inflamm Bowel Dis. 2024;30:820-828.
    

    >> Share

    
    
22. HEYDARI R, Fayazzadeh S, Shahrokh S, Shekari F, et al
    Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2023 Oct 19:izad219. doi: 10.1093.
    

    >> Share

    
    
23. BODEN EK, Kongala R, Hindmarch DC, Shows DM, et al
    Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells.
    Inflamm Bowel Dis. 2024;30:704-717.
    

    >> Share

    
    
24. LIMKETKAI BN, Maas L, Krishna M, Dua A, et al
    Machine Learning-based Characterization of Longitudinal Health Care Utilization Among Patients With Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2024;30:697-703.
    

    >> Share

    
    

    
    J Crohns Colitis

25. TAVARES DE SOUSA H, Ferreira M, Gullo I, Rocha AM, et al
    Fibrosis-related transcriptome unveils a distinctive remodeling matrix pattern in penetrating ileal Crohn's disease.
    J Crohns Colitis. 2024 May 3:jjae064. doi: 10.1093.
    

    >> Share

    
    
26. REGUEIRO M, Siegmund B, Yarur AJ, Steinwurz F, et al
    Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events From the ELEVATE UC Clinical Program.
    J Crohns Colitis. 2024 May 3:jjae060. doi: 10.1093.
    

    >> Share

    
    

    
    J Gastroenterol

27. IMAZU N, Torisu T, Yokote A, Umeno J, et al
    Arginase 2 attenuates ulcerative colitis by antioxidant effects of spermidine.
    J Gastroenterol. 2024 May 2. doi: 10.1007/s00535-024-02104.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

28. HOU D, Yu T, Lu X, Hong JY, et al
    Sirt2 inhibition improves gut epithelial barrier integrity and protects mice from colitis.
    Proc Natl Acad Sci U S A. 2024;121:e2319833121.
    

    >> Share

    
    

    
    Scand J Gastroenterol

29. FORSS A, Flis P, Sotoodeh A, Kapraali M, et al
    Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review.
    Scand J Gastroenterol. 2024 Apr 29:1-9. doi: 10.1080/00365521.2024.2345383.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share